The first important step in treating hormone-resistant prostate cancer (HRPC) is to find out if complete castrate levels are achieved or not. It has significant bearing on planning the further course of treatment. If the serum testosterone is at noncastrate level then further androgen suppression should be achieved.\[[@CIT1]\] If the castrate levels are achieved, then one could have options of either withdrawing antiandrogens or changing antiandrogens or trying intermittent androgen therapy or even trying secondary hormonal therapy. Continued androgen suppression with the same drugs or change of AA has been found to be effective in some patients.\[[@CIT2][@CIT3]\] Antiandrogen withdrawal has significant effect on the PSA decline -- the first report came in 1993 as 'Flutamide withdrawal syndrome'.\[[@CIT4]\] The overall response could be in the range of 15-33% lasting for more 3.5 + months to more than five months in various studies.\[[@CIT5]--[@CIT8]\]

Secondary hormonal therapy also has a significant role to play in HRPC. Its beneficial effect has been found to be in the range of 30-60% with drugs like ketocanazole and aminoglutethimide.\[[@CIT9]--[@CIT11]\] Use of diethylstilbestrol has shown a response rate of 20-40% in various studies.\[[@CIT12]\]
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Secondary hormonal therapy may include DES, ketocanazole, prednisolone, finasteride, dutasteride, estramustine, aminoglutethimide, etc.

  Noncastrate levels       
  ------------------------ -----------------------------------------
  Previous treatment       Plan of action
                           
  LH-RH analogues          Add antiandrogens\[[@CIT14]--[@CIT15]\]
  LH-RH + antiandrogens    Change antiandrogens\[[@CIT16]\]
                           Secondary orchidectomy
  AA alone                 Add LH-RH
                           Secondary orchidectomy?
                           Change AA
  Bilateral orchidectomy   Add antiandrogens
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  Clinical problems and the care                                    
  -------------------------------- -------------------------------- ------------------------------------------------------
  Clinical problem                 Options                          Comment
                                                                    
  BOO                              Indwelling catheter/SPC          High rate of incontinence
                                   Channel TURP                     after TURP
                                   Prostatic stents                 Blockage of stents
  Hematuria                        Bladder washout                  Haemostatic RT quiet useful
                                   Haemostatic agents               
                                   Haemostatic RT                   
  Urinary incontinence             Indwelling catheter              Can be nuisance despite catheterization
  Ureteric obstruction             Antegrade stenting               Most difficult problem is decision-making \'to
                                   PCN                              treat or not to treat\'.
                                   Steroids                         Certainly not for dialysislndividual situations
                                   Honvon                           may make decisions easier
                                   ? leave alone                    
  Bony pains                       NSAID                            Use 'WHO' ladder for pain relief\[[@CIT17]\]
                                   Opiates                          local RT effective
                                   Local RT                         Side-effect profile of NSAIDs, opiates,
                                   Biphosphonates                   strontium can be bothersome
                                   Strontium\[[@CIT18]\]            
                                   P-32                             
                                   Steroids                         
  Pathological fractures           Stabilization                    Fixation improves QOL and prevents inherent
                                   Postfixation-RT                  complications of fractures\[[@CIT19]\]
  Spinal cord compression          Steroids                         Timely treatment essential for impending
                                   Local RT                         neurodeficit
                                   Decompression                    A
  Anemia                           RBC component therapy            Overenthusiastic treatment to be avoided\[[@CIT20]\]
                                   Blood transfusion                
                                   Erythropoietin                   
                                   Bone marrow stimulants           
                                   Nutritional support              
  Coagulopathy                     Platelets, FFP?                  Apart from the disease, look for any drugs
                                   Heparin                          responsible for coagulation disorder
  Lymphoedema                      Steroids                         Rarely useful
                                   Stockings                        
  Rectal obstruction/              ? Colostomy                      Rarely justified
  rectovesical fistula             ? ? ? Urinary diversion          
  Psychological issues             Antidepressants                  Psycho-oncology is an emerging branch. Such
                                   Mood elevators                   professional help can be rewarding
                                   Counseling\[[@CIT21][@CIT22]\]   

AA - Antiandrogens, BOO - Bladder outflow obstruction, SPC - Suprapubic catheter, RT - Radiotherapy, FFP - Fresh frozen plasma

Secondary orchidectomy has a definite role to play if the castrate levels are not achieved. The response rate would be in the range of 5-70% depending on the prior hormone manipulation used and partly due to inconsistent use of the drugs.\[[@CIT13]\]
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